Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prostate cancer.
Lancet Oncol
; 24(10): 1056-1057, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37797626
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Neoplasms, Castration-Resistant
/
Abiraterone Acetate
Limits:
Humans
/
Male
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article